Shijiazhuang Xingbai Pharma Receives $18 Million in PE from Infinity

Shijiazhuang Xingbai Pharmaceutical Company of Hebei, a maker of biological pesticides, received a private equity investment of 120 million RMB ($18.3 million) from Israel-based Infinity. The financing is meant to increase Shijiazhuang Xingbai’s biotech capabilities, as the company makes plans for an IPO in the A-share market in three years. More details....